dual BRD4/PLK1 inhibitors (Central South University/Novartis)

N/A

Report date: 2025/03/19 09:01:36
NME

Base Information

Drug Namedual BRD4/PLK1 inhibitors (Central South University/Novartis)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolo like kinase 1 inhibitorsBromodomain-containing protein 4 inhibitors
TargetsPolo like kinase 1Bromodomain-containing protein 4
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCentral South University
China Registration ClassN/A

Develop Information

Active CompaniesNovartis AgCentral South University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A